Lupin Limited has informed the Exchange regarding a press release dated January 27, 2022, titled "Lupin Signs Promotional Agreement with Exeltis on SOLOSEC�� (secnidazole)expanding access for Adult Women Suffering with Bacterial Vaginosis and Adults with Trichomoniasis".